NCT05006859 Wheelchair Positioning and Neuromuscular Diseases
| NCT ID | NCT05006859 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupement Hospitalier Intercommunal du Vexin |
| Condition | Neuromuscular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2021-05-17 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2021-05-17 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This database will describe sitting postural control in wheelchair, as well as PW pain, and pressure ulcers associated with sitting, in patients with neuromuscular disease (NMD).
Eligibility Criteria
Inclusion Criteria : * Patient with neuromuscular disease * Written informed consent (IC) obtained * Adult patients (\> 18 years) Or * Adults under guardianship who has given theirs oral consent and guardian's consent obtained Or * Childs who has given theirs oral consent and parents' consent obtained * Wheelchair user Exclusion Criteria : • Patient not seen in positioning consultation by N. Pellegrini and / or E. Dupitierr
Contact & Investigator
Nadine Pellegrini
PRINCIPAL INVESTIGATOR
Groupement Hospitalier Intercommunal du Vexin
Frequently Asked Questions
Who can join the NCT05006859 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Neuromuscular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05006859 currently recruiting?
Yes, NCT05006859 is actively recruiting participants. Contact the research team at maryline.delattre@ght-novo.fr for enrollment information.
Where is the NCT05006859 trial being conducted?
This trial is being conducted at Aincourt, France, Évry, France.
Who is sponsoring the NCT05006859 clinical trial?
NCT05006859 is sponsored by Groupement Hospitalier Intercommunal du Vexin. The principal investigator is Nadine Pellegrini at Groupement Hospitalier Intercommunal du Vexin. The trial plans to enroll 50 participants.